ZIOP presenting at SNO this weekend.
AdRTShIL12 Plus Veledimex Presentations at SNO 2017 Poster Oral Presentation Oral PresentationPhase 1 Study of Ad RTShIL Veledimex12 plus in Pediatric Brain Tumors Stewart Goldman Lurie Children’s HospitalA Phase 1 study of Ad RTShIL veledimex , M.D., 12 + in adult recurrent glioblastoma Antonio Chiocca , M.D., Ph.D., Brigham and Women’s / Dana Cancer CenterFarber Controlled Expression of IL 12 Improves Survival in Glioma by Activating the Immune Response in Mice and Humans John A. Barrett , ZIOPHARM Conference call following SNO. Details to follow Ph.D., Oral Presentation Controlled Local Expression of IL12 as Gene Therapy Concomitant with Systemic Chemotherapy Improves Survival in Glioma John A. Barrett ZIOPHARM , Ph.D., Third Quarter 2017 Financial Results and Updates on Recent Activities
